CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-05-25 | BRACA JOHN N Director | Grant or award | +1,487 | $0.51 | $764 | 60,124 |
| 2010-05-25 | BRACA JOHN N Director | Conversion | +77,840 | $0.83 | $65K | 137,964 |
| 2010-05-25 | BRACA JOHN N Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | 0 | ||
| 2010-05-25 | FORBES CHRISTOPHER Director | Grant or award | +182,840 | $0.37 | $67K | 3,227,020 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Grant or award | +78,469 | $0.51 | $40K | 3,305,489 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Conversion | +4,101,800 | $0.83 | $3.4M | 7,407,289 |
| 2010-05-25 | FORBES CHRISTOPHER Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | $0.83 | $0 | 0 |
| 2010-05-25 | Isabelle Warren John Director | Grant or award | +3,470 | $0.37 | $1K | 22,437 |
| 2010-05-25 | Isabelle Warren John Director | Grant or award | +1,487 | $0.51 | $764 | 23,924 |
| 2010-05-25 | Isabelle Warren John Director | Conversion | +77,840 | $0.83 | $65K | 101,764 |
| 2010-05-25 | Isabelle Warren John Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | $0.83 | $0 | 0 |
| 2010-05-25 | STALDER RUEDI Director | Grant or award | +28,135 | $0.37 | $10K | 410,684 |
| 2010-05-25 | STALDER RUEDI Director | Grant or award | +12,078 | $0.51 | $6K | 422,762 |
| 2010-05-25 | STALDER RUEDI Director | Conversion | +631,176 | $0.83 | $524K | 1,053,938 |
| 2010-05-25 | STALDER RUEDI Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | $0.83 | $0 | 0 |
| 2010-05-25 | Van Hulst Jack Director | Grant or award | +1,358 | $0.37 | $499 | 9,021 |
| 2010-05-25 | Van Hulst Jack Director | Grant or award | +588 | $0.51 | $302 | 9,609 |
| 2010-05-25 | Van Hulst Jack Director | Conversion | +30,459 | $0.83 | $25K | 40,068 |
| 2010-05-25 | Van Hulst Jack Director | Exercise or conversion · Convertible Debenture Due 12/31/2010 | −0 | 0 | ||
| 2010-05-25 | RECTOR DAVID Director | Grant or award | +7,090 | $0.37 | $3K | 68,641 |
Page 29 of 38 · 754 trades